Lazard Asset Management
NUTX

Lazard Asset Management’s Nutex Health NUTX Stock Holding History

Lazard Asset Management’s Portfolio NUTX Stock Details NUTX Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q1 		– Sell
-14,088
Closed -$2.32M – 2021
2025
Q4 		$2.32M Buy
+14,088
New +$1.87M ﹤0.01% 803
2025
Q3 		– Sell
-18,989
Closed -$2.36M – 2161
2025
Q2 		$2.36M Buy
18,989
+18,676
+5,967% +$2.41M ﹤0.01% 960
2025
Q1 		$14K Buy
313
+207
+195% +$10.1K ﹤0.01% 2130
2024
Q4 		$3K Sell
106
-36
-25% -$1.03K ﹤0.01% 2166
2024
Q3 		$3K Buy
+142
New +$2.05K ﹤0.01% 2072

Other funds holding NUTX

BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
PP
Pertento Partners London, United Kingdom $1.37B AUM 36.36% 1-Year Est. Return
VCM
Vanguard Capital Management Malvern, Pennsylvania $4.04T AUM
American Century Companies
American Century Companies Kansas City, Missouri $194B AUM 35% 1-Year Est. Return
TCM
Topline Capital Management Santa Monica, California $605M AUM 26.24% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return
Millennium Management
Millennium Management New York $240B AUM 35.51% 1-Year Est. Return
UBS Group
UBS Group Zurich, Switzerland $666B AUM 30.12% 1-Year Est. Return
WC
Winmill & Co Rochester, New York $347M AUM 37.48% 1-Year Est. Return

Lazard Asset Management's NUTX Position: Q1 2026 in Review

Lazard Asset Management sold out of Nutex Health (NUTX) in Q1 2026, closing a stake of 14,088 shares — an estimated $2.32M sold.

Lazard Asset Management first reported a position in NUTX in Q3 2024 and held it in 5 quarters. The position peaked at $2.36M in Q2 2025. 129 funds tracked by Wall St. Rank hold NUTX as of Q1 2026.

  • Lazard Asset Management reported no remaining Nutex Health position as of Q1 2026 after selling out during the quarter.
  • Lazard Asset Management sold 14,088 Nutex Health shares in Q1 2026, an estimated $2.32M.
  • Lazard Asset Management first reported a position in Nutex Health in Q3 2024 and held it in 5 quarters.
  • Lazard Asset Management's Nutex Health position peaked at $2.36M in Q2 2025.
  • 129 funds tracked by Wall St. Rank held Nutex Health as of Q1 2026.

Based on Lazard Asset Management's 13F filing for Q1 2026, filed 15 May 2026.